Next Article in Journal
Bergamot Polyphenol Fraction Exerts Effects on Bone Biology by Activating ERK 1/2 and Wnt/β-Catenin Pathway and Regulating Bone Biomarkers in Bone Cell Cultures
Previous Article in Journal
Food Rating Scale in Food Services: From Development to Assessment of a Strategy for Consumer Healthier Choices
Open AccessArticle

Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced Cardiotoxicity

1
Division of Cardiology, Istituto Nazionale Tumori–IRCCS-Fondazione G.Pascale, 80131 Napoli, Italy
2
Center for Advanced Biomaterial for Health Care (CABHC), Istituto Italiano di Tecnologia, Largo Barsanti e Matteucci 53, 80125 Naples, Italy
3
Department of Pharmacy, University of Naples Federico II, via D. Montesano 49, 80131 Naples, Italy
4
Department of Medical Oncology, Istituto Nazionale Tumori–IRCCS-Fondazione G.Pascale, 80131 Napoli, Italy
5
Scientific Direction, Istituto Nazionale Tumori–IRCCS-Fondazione G.Pascale, 80131 Napoli, Italy
*
Authors to whom correspondence should be addressed.
Nutrients 2018, 10(9), 1304; https://doi.org/10.3390/nu10091304
Received: 10 August 2018 / Revised: 11 September 2018 / Accepted: 12 September 2018 / Published: 14 September 2018
Doxorubicin is a highly active antineoplastic agent, but its clinical use is limited because of its cardiotoxicity. Although nutraceuticals endowed with anti-inflammatory properties exert cardioprotective activity, their bioavailability and stability are inconsistent. In an attempt to address this issue, we evaluated whether bioavailable nanoemulsions loaded with nutraceuticals (curcumin and fresh and dry tomato extracts rich in lycopene) protect cardiomyoblasts (H9C2 cells) from doxorubicin-induced toxicity. Nanoemulsions were produced with a high-pressure homogenizer. H9C2 cells were incubated with nanoemulsions loaded with different nutraceuticals alone or in combination with doxorubicin. Cell viability was evaluated with a modified MTT method. The levels of the lipid peroxidation products malondialdehyde (MDA) and 4-hydroxy-2-butanone (4-HNA), and of the cardiotoxic-related interleukins IL-6, IL-8, IL-1β and IL-10, tumor necrosis factor-alpha (TNF-α), and nitric oxide were analyzed in cardiomyoblasts. The hydrodynamic size of nanoemulsions was around 100 nm. Cell viability enhancement was 35–40% higher in cardiomyoblasts treated with nanoemulsion + doxorubicin than in cardiomyoblasts treated with doxorubicin alone. Nanoemulsions also protected against oxidative stress as witnessed by a reduction of MDA and 4-HNA. Notably, nanoemulsions inhibited the release of IL-6, IL-8, IL-1β, TNF-α and nitric oxide by around 35–40% and increased IL-10 production by 25–27% versus cells not treated with emulsions. Of the nutraceuticals evaluated, lycopene-rich nanoemulsions had the best cardioprotective profile. In conclusion, nanoemulsions loaded with the nutraceuticals described herein protect against cardiotoxicity, by reducing inflammation and lipid oxidative stress. These results set the stage for studies in preclinical models. View Full-Text
Keywords: cardiology; nanomedicine; nutraceuticals; doxorubicin; cytokines cardiology; nanomedicine; nutraceuticals; doxorubicin; cytokines
Show Figures

Graphical abstract

MDPI and ACS Style

Quagliariello, V.; Vecchione, R.; Coppola, C.; Di Cicco, C.; De Capua, A.; Piscopo, G.; Paciello, R.; Narciso, V.; Formisano, C.; Taglialatela-Scafati, O.; Iaffaioli, R.V.; Botti, G.; Netti, P.A.; Maurea, N. Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced Cardiotoxicity. Nutrients 2018, 10, 1304.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop